Nagarajan
About Nagarajan
Data last updated:
Nagarajan is a Director at Datri Blood Stem Cell Donors Registry (since 2019) and Director at Histogenetics (India) Private Limited (since 2016). The companies operate in Healthcare and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹30.69 Cr; the largest is Datri Blood Stem Cell Donors Registry at ₹22.34 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Datri Blood Stem Cell Donors Registry U85190TN2009NPL070883 | Director | 30 Nov 2019 | 2009 | ₹22.34 Cr (FY 2024) | Active |
_PRIVATE_LIMITED.webp){kind=small} Histogenetics (India) Private Limited U72900TN2006PTC061761 | Director | 06 Jun 2016 | 2006 | ₹8.35 Cr (FY 2024) | Active |
Board colleagues of Nagarajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lakshmi Subramanian | Datri Blood Stem Cell Donors Registry | Manager | |
| Nezih Vahid Cereb | 01451283 | Datri Blood Stem Cell Donors Registry , Histogenetics (India) Private Limited | Director |
| Soo Young Lee | 01451180 | Datri Blood Stem Cell Donors Registry , Histogenetics (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagarajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagarajan
Nagarajan currently holds 2 directorships: Datri Blood Stem Cell Donors Registry (Director, since 30 Nov 2019, revenue ₹22.34 Cr (FY 2024)); Histogenetics (India) Private Limited (Director, since 06 Jun 2016, revenue ₹8.35 Cr (FY 2024)).
Nagarajan was first appointed on 06 Jun 2016 as Director at Histogenetics (India) Private Limited. The most recent appointment on record is 30 Nov 2019 at Datri Blood Stem Cell Donors Registry.
The 2 current companies of Nagarajan that report revenue have a combined latest revenue of ₹30.69 Cr: Datri Blood Stem Cell Donors Registry ₹22.34 Cr (FY 2024); Histogenetics (India) Private Limited ₹8.35 Cr (FY 2024).
The current boards of Nagarajan's companies include Lakshmi Subramanian (Datri Blood Stem Cell Donors Registry), Nezih Vahid Cereb (Datri Blood Stem Cell Donors Registry), Soo Young Lee (Datri Blood Stem Cell Donors Registry).